Pathohistologic findings in patients with nonseminomatous germ cell tumors (NSGCT) who undergo postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) for small tumors

MLA

Axel Heidenreich, et al. “Pathohistologic Findings in Patients with Nonseminomatous Germ Cell Tumors (NSGCT) Who Undergo Postchemotherapy Retroperitoneal Lymph Node Dissection (PC-RPLND) for Small Tumors.” Journal of Clinical Oncology, vol. 29, Mar. 2011, p. 224. EBSCOhost, https://doi.org/10.1200/jco.2011.29.7_suppl.224.

APA

Axel Heidenreich, Peter Albers, Mark Schrader, Klaus-Peter Dieckmann, David J. K. P. Pfister, C. Winter, Jonas Busch, & Hans U. Schmelz. (2011). Pathohistologic findings in patients with nonseminomatous germ cell tumors (NSGCT) who undergo postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) for small tumors. Journal of Clinical Oncology, 29, 224. https://doi.org/10.1200/jco.2011.29.7_suppl.224

Chicago

Axel Heidenreich, Peter Albers, Mark Schrader, Klaus-Peter Dieckmann, David J. K. P. Pfister, C. Winter, Jonas Busch, and Hans U. Schmelz. 2011. “Pathohistologic Findings in Patients with Nonseminomatous Germ Cell Tumors (NSGCT) Who Undergo Postchemotherapy Retroperitoneal Lymph Node Dissection (PC-RPLND) for Small Tumors.” Journal of Clinical Oncology 29 (March): 224. doi:10.1200/jco.2011.29.7_suppl.224.